CLRB   $2.11  0.96% Market Closed After Close 2.1 -0.47%

Cellectar Biosciences Inc
Total Cash 40.03M
totalCashPerShare 1.117
EBITDA -42.02M
Total Debt 548.34K
quickRatio 2.461
currentRatio 2.543
Total Revenue
debtToEquity 2.096
Revenue/Share
ROA -0.91470003
ROE -3.04376
grossProfits
freeCashflow -15.49M
operatingCashflow -38.55M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 52.52M
forwardPE -0.7385159
floatShares 26.16M
sharesOutstanding 35.85M
sharesShort 2.20M
sharesShortPriorMonth 2.57M
dateShortInterest
sharesPercentSharesOut 0.06%
heldPercentInsiders 0.03%
heldPercentInstitutions 0.35%
Short Ratio help_outline 9.23%
shortPercentOfFloat 0.07%
impliedSharesOutstanding
bookValue 0.274
Price To Book help_outline 7.63
earningsQuarterlyGrowth
netIncomeToCommon -50.98M
trailingEps -3.09%
forwardEps -2.83%
enterpriseToEbitda -1.25
lastDividendValue
lastDividendDate
currentQuarterEstimate -1.0 4Q 2022
institutionsCount 41
lastUpdated Oct. 21, 2024, 2:31 p.m.